Prepare for This Meeting
Read Article Summaries From Top Medical Journals
Economic burden of cancer across the European Union: a population-based cost analysis
The Lancet Oncology, January 2, 2014
Clinical significance of RKIP mRNA expression in non-small cell lung cancer
Tumor Biology, January 21, 2014
Cancer treatment disparities in HIV-infected individuals in the United States
Journal of Clinical Oncology, July 22, 2014
Prognostic value of baseline survival determined for 11 types of cancer
ScienceDaily, November 7, 2013
Free full text
Monitoring tumor-derived cell-free DNA in patients with solid tumors: Clinical perspectives and research opportunities
Cancer Treatment Reviews, November 5, 2013
Related Quizzes From Smartest Doc
Question: True or False: The use of IV bisphosphonates for prevention of skeletal-related events (SREs) is higher in patients with bone metastases due to metastatic breast cancer than in patients with metastatic prostate cancer or metastatic lung cancer.
Question: Which cancer patients are most likely to present with bone fractures?
Question: Which bisphosphonate was the most efficacious in a mixed-treatment meta-analysis for reducing the risk of skeletal-related events (SREs) in patients with metastatic breast or prostate cancer?